VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Q2 2025 Earnings Call Transcript November 10, 2024 Operator: Good afternoon, ladies and gentlemen, and welcome to the Vistagen Therapeutics Fiscal Year 2025 ...
As global markets experience a rally driven by expectations of growth and tax reforms following recent U.S. elections, small-cap stocks like those in the Russell 2000 Index have shown significant ...
Here we highlight a subset of our preferred stocks from the screener. Overview: JNTC Co., Ltd. operates in South Korea, offering products such as connectors, hinges, and tempered glass, with a market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback